| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10032442 | American Journal of Obstetrics and Gynecology | 2005 | 8 Pages |
Abstract
Our results strongly support the estrogen agonist role of tamoxifen as the causative factor for the increased risk of endometrial polyps, leiomyomas, endometriosis, and endometrial hyperplasia among women taking this agent.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
Eva MD, Joseph P. DrPH, D. Lawrence MD, Norman MD, George C. MD, Cynthia MD, Carolyn D. MD,